(Q44847750)

English

The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study

scientific article published in May 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 December 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study. (English)

1 reference

Europe PubMed Central

6 December 2017

0 references

diabetic nephropathy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

6 December 2017

author name string

R Rachmani

1

1 reference

Europe PubMed Central

6 December 2017

I Slavachevsky

2

1 reference

Europe PubMed Central

6 December 2017

M Amit

3

1 reference

Europe PubMed Central

6 December 2017

Y Kedar

5

1 reference

Europe PubMed Central

6 December 2017

M Berla

6

1 reference

Europe PubMed Central

6 December 2017

M Ravid

7

1 reference

Europe PubMed Central

6 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 2004

1 reference

Europe PubMed Central

6 December 2017

Diabetic Medicine

1 reference

Europe PubMed Central

6 December 2017

21

1 reference

Europe PubMed Central

6 December 2017

5

1 reference

Europe PubMed Central

6 December 2017

471-475

1 reference

Europe PubMed Central

6 December 2017

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

Efficacy of eplerenone added to renin-angiotensin blockade in hypertensive patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

Clinical implications of aldosterone blockade

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

Economic evaluation of the randomized aldactone evaluation study (RALES): treatment of patients with severe heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

Aldosterone: cardiovascular assault.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

Aldosterone Inhibits Inducible Nitric Oxide Synthase in Neonatal Rat Cardiomyocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

Aldosterone as a mediator in cardiovascular injury

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

Aldosterone regulates the Na-K-2Cl cotransporter in vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

Nongenomic effect of aldosterone on Na+,K+-adenosine triphosphatase in arterial vessels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

Nongenomic effects of aldosterone on human renal cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

Resistance artery mechanics and composition in angiotensin II-infused rats: effects of aldosterone antagonism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

Renoprotection by ACE inhibition or aldosterone blockade is blood pressure-dependent

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

Effectiveness of aldosterone blockade in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

[Serum creatinine determination without protein precipitation]

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

Effect of an alpha-adrenergic blocker, and ACE inhibitor and hydrochlorothiazide on blood pressure and on renal function in type 2 diabetic patients with hypertension and albuminuria. A randomized cross-over study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01194.X

21 January 2018

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1464-5491.2004.01194.X

Recent landmark clinical trials: how do they modify the therapeutic paradigm?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1464-5491.2004.01194.X

Identifiers

10.1111/J.1464-5491.2004.01194.X

1 reference

Europe PubMed Central

6 December 2017

1 reference

Europe PubMed Central

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44847750&oldid=2053819344"